PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome

Human Molecular Genetics

Volumn 8, Issue 8, 1999, Pages 1461-1472

  Marsh, Debbie J ^a,b   Kum, Jennifer B ^a,b   Lunetta, Kathryn L ^c   Bennett, Michael J ^d   Gorlin, Robert J ^e   Ahmed, S Faisal ^f   Bodurtha, Joann ^g   Crowe, Carol ^h   Curtis, Mary A ⁱ   Dasouki, Majed ^j   Dunn, Teresa ^k   Feit, Howard ^l   Geraghty, Michael T ^m   Graham Jr , John M ⁿ   Hodgson, Shirley V ^o   Hunter, Alasdair ^p   Korf, Bruce R ^q   Manchester, David ^r   Miesfeldt, Susan ^s   Murday, Victoria A ^t   Nathanson, Katherine L ^u   Parisi, Melissa ^v   Pober, Barbara ^w   Romano, Corrado ^x   Tolmie, John L ^y   Trembath, Richard ^z   Winter, Robin M ^aa   Zackai, Elaine H ^u   Zori, Roberto T ^ab   Weng, Liang Ping ^a,b   Dahia, Patricia L M ^a,b   Eng, Charis ^a,ac   more..

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g Children's Hospital   (United States)

^h METROHEALTH MEDICAL CENTER   (United States)

ⁱ ARKANSAS CHILDREN S HOSPITAL   (United States)

^j VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l HENRY FORD HOSPITAL   (United States)

^m JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ CEDARS SINAI MEDICAL CENTER   (United States)

^o KING S COLLEGE HOSPITAL   (United Kingdom)

^p CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^q BOSTON CHILDREN S HOSPITAL   (United States)

^r UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF VIRGINIA   (United States)

^t ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^u UNIVERSITY OF PENNSYLVANIA   (United States)

^v SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^w YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x OASI RESEARCH INSTITUTE IRCCS   (Italy)

^y UNIVERSITY OF GLASGOW   (United Kingdom)

^z UNIVERSITY OF LEICESTER   (United Kingdom)

^aa GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^ab UNIVERSITY OF FLORIDA   (United States)

^ac UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATASE;

ARTICLE; BANNAYAN RILEY RUVALCABA SYNDROME; BREAST FIBROADENOMA; CANCER; CLINICAL ARTICLE; COWDEN SYNDROME; GENE MUTATION; GENOTYPE; HAMARTOMA; HUMAN; HUMAN CELL; LIPOMA; PHENOTYPE; PRIORITY JOURNAL; SYNDROME DELINEATION; TUMOR SUPPRESSOR GENE;

ABNORMALITIES, MULTIPLE; CELLS, CULTURED; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; COHORT STUDIES; CRANIOFACIAL ABNORMALITIES; FAMILY HEALTH; FEMALE; GENETIC MARKERS; GENOTYPE; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MENTAL RETARDATION; MUTATION; PEDIGREE; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SYNDROME; TUMOR SUPPRESSOR PROTEINS;

GLANS;

EID: 0032853452     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.8.1461     Document Type: Article

References (46)

1. Carlson, H.E., Burns, T.W., Davenport, S.L., Luger, A.M., Spence, M.A., Sparkes, R.S. and Orth, D.N. ( 1984) Cowden disease: gene marker studies and measurements of epidermal growth factor. Am. J. Hum. Genet., 38, 908-917.
2. Hanssen, A.M.N. and Fryns, J.P. (1995) Cowden syndrome. J. Med. Genet., 32, 117-119.
3. Longy, M. and Lacombe, D. (1996) Cowden disease. Report of a family and review. Ann. Genet., 39, 35-42.
4. Eng, C. (1997) Cowden syndrome. J. Genet. Counsel., 6, 181-191.
5. Starink, T.M., van der Veen, J.P.W., Arwert, F., de Waal, L.P., de Lange, G.G., Gille, J.J.P. and Eriksson, A.W. (1986) The Cowden syndrome: a clinical and genetic study in 21 patients. Clin. Genet., 29, 222-233.
6. Padberg, G.W., Schot, J.D., Vielvoye, G.J., Bots, G.T. and de Beer, F.C. (1991) Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann. Neurol., 29, 517-523.
7. Albrecht, S., Haber, R.M., Goodman, J.C. and Duvic, M. (1992) Cowden syndrome and Lhermitte-Duclos disease. Cancer, 70, 869-876.
8. Vinchon, M., Blond, S., Lejeune, J.P., Krivosik, I., Fossati, P., Assaker, R. and Christiaens, J.L. (1994) Association of Lhermitte-Duclos and Cowden disease: report of a new case and review of the literature. J. Neurol. Neurosurg. Psychiatr., 57, 699-704.
9. Eng, C., Murday, V., Seal, S., Mohammed, S., Hodgson, S.V., Chaudary, M.A., Fentiman, I.S., Ponder, B.A. and Eeles, R.A. (1994) Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J. Med. Genet., 31, 458-461.
10. Bannayan, G.A. (1971) Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch. Pathol., 92, 1-5.
11. Gorlin, R.J., Cohen, M.M., Condon, L.M. and Burke, B.A. (1992) Bannayan-Riley-Ruvalcaba syndrome. Am. J. Med. Genet., 44, 307-314.
12. Zonana, J., Rimoin, D.L. and Davis, D.C. (1976) Macrocephaly with multiple lipomas and hemangiomas. J. Paediatr., 89, 600-603.
13. Tsou, H.C., Teng, D., Ping, X.I., Broncolini, V., Davis, T., Hu, R., Xie, X.-X., Gruener, A.C., Schrager, C.A., Christiano, A.M., Eng, C., Steck, P., Ott, J., Tavitigian, S.V. and Peacocke, M. (1997) Mutations in early onset breast cancer associated with Cowden syndrome and absence of mutations in other individuals with early onset breast cancer. Am. J. Hum. Genet., 61, 1036-1043.
14. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L.M., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C. and Parsons, R. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet., 16, 64-67.
15. Nelen, M.R., van Staveren, W.C.G., Peelers, E.A.J., Hassel, M.B., Gorlin, R.J., Hamm, H., Lindboe, C.F., Fryns, J.-P., Sijmons, R.H., Woods, D.G., Mariman, E.C.M., Padberg, G.W. and Kremer, H. (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet., 6, 1383-1387.
16. Marsh, D.J., Coulon, V., Lunetta, K.L., Rocca-Serra, P., Dahia, P.L.M., Zheng, Z., Liaw, D., Caron, S., Duboué, B., Lin, A.Y., Richardson, A.L., Bonnetblanc, J.M., Bressieux, J.M., Moreau, A.C., Chompret, A., Demange, L., Eeles, R.A., Yohanda, A.M., Fearon, E.R., Fricker, J.P., Gorlin, R.J., Hodgson, S.V., Huson, S., Lacombe, D., LePrat, F., Odent, S., Toulouse, C., Olopade, O.I., Sobol, H., Tishler, S., Woods, C.G., Robinson, B.C., Weber, C., Parsons, R., Peacocke, M., Longy, M. and Eng, C. (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet., 7, 507-515.
17. Longy, M., Coulon, V., Duboué, B., David, A., Larrégue, M., Eng, C., Amati, P., Kraimps, J.-L., Bottani, A., Lacombe, D. and Bonneau, D. (1998) Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype. J. Med. Genet., 35, 886-889.
18. Myers, M.P., Stolarov, J.P., Eng, C., Li, J., Wang, S.I., Wigler, M.H., Parsons, R. and Tonks, N.K. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual specificity phosphatase. Proc. Natl Acad. Sci. USA, 94, 9052-9057.
19. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittman, M., Tyoko, B., Hibshoosh, H., Wigler, M.H. and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science, 275, 1943-1947.
20. Steck, P.A., Pershouse, M.A., Jasser, S.A., Alfred Yung, W.K., Lin. H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D.H.F. and Tavtigian, S.V. (1997) Identification of a candidate tumour suppressor gene, MMAC 1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet., 15, 356-362.
21. Li, D.-M. and Sun, H. (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57, 2124-2129.
22. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P. and Mak, T.W. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39.
23. Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, B.A., Wigler, M.H., Downes, C.P. and Tonks, N.K. (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl Acad. Sci. USA, 95, 13513-13518.
24. Dahia, P.L.M., Aguiar, R.C.T., Alberta, J., Kum, J.B., Caron, S., Sill, H., Marsh, D.J., Ritz, J., Freedman, A., Stiles, C. and Eng, C. (1999) PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in hematological malignancies. Hum. Mol. Genet., 8, 185-193.
25. Maehama, T. and Dixon, J.E. (1998) The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem., 273, 13375-13378.
26. Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M.P., Tonks, N. and Parsons, R. (1998) The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res., 58, 5667-5672.
27. Caroll, B.T., Couch, F.J., Rebbeck, T.R. and Weber, B.L. (1999) Polymorphisms in PTEN in breast cancer families. J. Med. Genet., 36, 94-96.
28. Dahia, P.L.M., Marsh, D.J., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R., Longy, M., Larsson, C. and Eng, C. (1997) Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res., 57, 4710-4713.
29. Cairns, P., Ookami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J.G., Jen, J., Isaacs, W.B., Bova, G.S. and Sidransky, D. (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000.
30. Marsh, D.J., Zheng, Z., Zedenius, J., Kremer, H., Padberg, G.W., Larsson, C., Longy, M. and Eng, C. (1997) Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res., 57, 500-503.
31. Marsh, D.J., Dahia, P.L.M., Coulon, V., Zheng, Z., Dorion-Bonnet, F., Call, K.M., Little, R., Lin, A.Y., Eeles, R.A., Goldstein, A.M., Hodgson, S.V., Richardson, A.-L., Robinson, B.G., Weber, H.C., Longy, M. and Eng, C. (1998) Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer, 21, 61-69.
32. Arch, E.M., Goodman, B.K., Wesep, R.A.V., Liaw, D., Clarke, K., Parsons, R., McKusick, V.A. and Geraghty, M.T. (1997) Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am. J. Med. Genet., 71, 489-493.
33. Tsuchiya, K.D., Wiesner, G., Casidy, S.B., Limwongse, C., Boyle, J.T. and Schwartz, S. (1998) Deletion 10q23.2-23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chromosomes Cancer, 21, 113-118.
34. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M. and Mak, T.W. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol., 8, 1169-1178.
35. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P.P. (1998) Pten is essential for embryonic development and tumour suppression. Nature Genet., 19, 348-355.
36. Elston, D.M., James, W.D., Rodman, O.G. and Graham, G.F. (1986) Multiple hamartoma syndrome (Cowden's disease) associated with non-Hodgkin's lymphoma. Arch. Dermatol., 122, 572-575.
37. Carethers, J.M., Funari, F.B., Zigman, A.F., Lavine, J.E., Jones, M.C., Graham, G.E., Teebi, A.S., Huang, H.-J.S., Ha, H.T., Chauhan, D.P., Chang, C.L., Cavenee, W.K. and Boland, R.B. (1998) Absence of PTEN/ MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res., 58, 2724-2726.
38. 1 growth arrest in glioma cells Cancer Res., 58, 5002-5008.
39. Mathew, C.G., Smith, B.A., Thorpe, K., Wong, Z., Royle, N.J., Jeffreys, A.J. and Ponder, B.A.J. (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature, 328, 524-526.
40. Marsh, D.J., Roth, S., Lunetta, K.L., Sistonen, P., Dahia, P.L.M., Hemminki, A., Zheng, Z., Caron, S., van Orsouw, N.J., Bodmer, W.F., Cottrell, S.E., Dunlop, M.G., Eccles, D., Hodgson, S.V., Järvinen, H., Kellokumpu, I., Markie, D., Neale, K., Phillips, R., Rosen, P., Syngal, S., Vijg, J., Tomlinson, I.P.M., Aaltonen, L. and Eng, C. (1997) Exclusion of PTEN/MMAC1/TEP1 and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome (JPS). Cancer Res., 57, 5017-5021.
41. Marsh, D.J., Dahia, P.L.M., Caron, S., Kum, J.B., Frayling, I.M., Tomlinson, I.P.M., Hughes, K., Eeles, R.A., Hodgson, S.V., Murday, V.A., Houlston, R. and Eng, C. (1998) Germline PTEN mutations in 'Cowden syndrome-like families'. J. Med. Genet., 35, 881-885.
42. Guldberg, P., Straten, P.T., Birck, A., Ahrenkiel, V., Kirkin, A.F. and Zeuthen, J. (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57, 3660-3663.
43. Mulligan, L.M., Marsh, D.J., Robinson, B.C., Schuffenecker, I., Zedenius, J., Lips, C.J.M., Gagel, R.F., Takai, S.I., Noll, W.W., Niederle, B., Raue, F., Lacroix, A., Thibodeau, S.N., Frilling, A., Ponder, B.A.J. and Eng, C. for the International RET Mutation Consortium (1995) Genotype-phenotype correlation in MEN 2: report of the International RET Mutation Consortium. J. Int. Med., 238, 343-346.
44. Eng, C., Clayton, D., Schuffenecker, I., Lenoir, G., Cote, G., Gagel, R.F., Ploos van Amstel, H.K., Lips, C.J.M., Nishisho, I., Takai, S.-I., Marsh, D.J., Robinson, B.G., Frank-Raue, K., Raue, F., Xue, F., Noll, W.W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjöld, M., Komminoth, P., Hendy, G.N., Gharib, H., Thibodeau, S.N., Lacroix, A., Frilling, A., Ponder, B.A.J. and Mulligan, L.M. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. J. Am. Med. Assoc., 276, 1575-1579.
45. Mehta, C.R. and Patel, N.R. (1983) A network algorithm for performing Fisher's exact test in rXc contingency tables. J. Am. Statistical Assoc., 78, 427-434.
46. Agresti, A. (1990) Categorical Data Analysis. John Wiley and Sons, New York.